Norman Noble to expand operations

Norman Noble, Inc., a family owned and operated medical device contract manufacturer, has begun improvements on a new 50,000ft² facility in Highland Heights, Ohio. The new facility will provide additional manufacturing space to meet medical OEM customers’ growing requirements for products, including nitinol-based structural heart implants and neurovascular devices as well as multileaf collimator (MLC) assemblies used in cancer radiation therapy equipment. The new facility is scheduled to be operational in Q4-2020.

“The additional facility is needed to support demand growth for next-gen products. The additional space will also provide our customers with production surge capacity. We are very excited to grow our facilities and expand our team of highly skilled associates as we continue to strengthen our partnerships with the world’s largest medical companies,” says Chris Noble, COO at Norman Noble.

Norman Noble manufactures medical devices and implants to customer specifications in compliance with FDA regulation 21 CFR part 820 and ISO 13485:2016. State-of-the-art processes include laser machining and welding, Swiss turning and milling, conventional and wire EDM, high-speed seven-axis contour milling, nitinol shape setting, and clean room assembly and packaging.